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Background: DNA methylation ensures genome integrity and regulates gene expression in diverse eukaryotes. In
Arabidopsis, methylation occurs in three sequence contexts: CG, CHG and CHH. The initial establishment of DNA
methylation at all three sequence contexts occurs through a process known as RNA-directed DNA methylation
(RdDM), in which small RNAs bound by Argonaute4 (AGO4) guide DNA methylation at homologous loci through
the de novo methyltransferase DRM2. Once established, DNA methylation at each of the three sequence contexts is
maintained through different mechanisms. Although some players involved in RdDM and maintenance methylation
have been identified, the underlying molecular mechanisms are not fully understood. To aid the comprehensive
identification of players in DNA methylation, we generated a transgenic reporter system that permits genetic and
chemical genetic screens in Arabidopsis.
Results: A dual 35S promoter (d35S) driven luciferase (LUC) reporter was introduced into Arabidopsis and LUCL, a
line with a low basal level of luciferase activity, was obtained. LUCL was found to be a multi-copy, single-insertion
transgene that contains methylated cytosines in CG, CHG and CHH contexts, with the highest methylation in the
CG context. Methylation was present throughout the promoter and LUC coding region. Treatment with an inhibitor
of cytosine methylation de-repressed luciferase activity. A mutation in MET1, which encodes the CG maintenance
methyltransferase, drastically reduced CG methylation and de-repressed LUC expression. Mutations in AGO4 and
DRM2 also de-repressed LUC expression, albeit to a smaller extent than loss of MET1. Using LUCL as a reporter line,
we performed a chemical screen for compounds that de-repress LUC expression, and identified a chemical,
methotrexate, known to be involved in biogenesis of the methyl donor.
Conclusion: We developed a luciferase-based reporter system, LUCL, which reports both RdDM and CG
maintenance methylation in Arabidopsis. The low basal level of LUCL expression provides an easy readout in genetic
and chemical genetic screens that will dissect the mechanisms of RdDM and methylation maintenance.
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An epigenetic modification that influences gene expres-
sion and genome stability is cytosine DNA methylation,
which involves the addition of a methyl group to the five
position of the pyrimidine cytosine. This mark in trans-
posable elements or intergenic regions is often associated
with transcriptional gene silencing (TGS) and contributes* Correspondence: xuemei.chen@ucr.edu
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reproduction in any medium, provided the orto genome stability. In Arabidopsis, de novo methylation
is guided by small and long noncoding RNAs and is re-
ferred to as RNA-directed DNA methylation (RdDM).
The RdDM pathway can be divided into three main
components. First, in an unknown manner, RNA poly-
merase IV (Pol IV) is recruited to target loci and gener-
ates single-stranded RNA (ssRNA). Second, the ssRNA
is made double-stranded by RNA-Dependent RNA
Polymerase 2, and the double-stranded RNA is further
processed into 24 nucleotide (nt) siRNAs by DICER-
LIKE 3. One strand is loaded into Argonaute4 (AGO4),
the major effector protein of 24 nt siRNAs. Third, in
parallel, RNA polymerase V (Pol V) is also recruited tod. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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long noncoding transcripts. It has been proposed that
these transcripts act as a scaffold for the recruitment of
the siRNA-AGO4 complex. This further facilitates the
recruitment of other downstream effectors such as In-
volved In De Novo 2 and the de novo methyltransferase
DRM2 to methylate these loci (reviewed in [1]). Al-
though many genes in this pathway have been identified,
key outstanding questions on the underlying molecular
mechanisms of RdDM remain to be answered.
In Arabidopsis, there are three types of cytosine me-
thylation: CG, CHG and CHH. CG and CHG are consid-
ered symmetric methylation, whereas CHH methylation
is considered asymmetric methylation. The three types
of DNA methylation are all established by RdDM, but
are maintained via different mechanisms after DNA rep-
lication. CHH methylation is maintained by constant de
novo methylation by DRM2 and other players in the
RdDM pathway. CHG methylation is maintained by a
reinforced loop between the DNA methyltransferase
Chromomethylase3 and histone modifications (reviewed
in [1]). CG methylation is maintained by DNA Methyl-
transferase 1 (MET1) and intriguingly, MET1 has been
shown to also be required for full levels of de novo
methylation of CG dinucleotides [2].
The players involved in CG maintenance methylation
are conserved between mammals and plants. Specifically,
in mammals, newly replicated DNA is hemi-methylated
and DNMT1, the MET1 ortholog in mammals, is respon-
sible for methylating the newly synthesized strand [3].
DNMT1 is recruited to newly replicated DNA through
interactions with UHRF1 and PCNA. UHRF1 specifi-
cally binds to hemi-methylated CG dinucleotides [4-7],
and PCNA is present at the replication fork [8]. In
Arabidopsis, CG maintenance methylation is mediated
by MET1 [2] and three Variant In Methylation genes
(VIM1-3), which are orthologs of UHRF1 [9,10]. Like in
mammals, the recruitment of VIM1 to hemi-methylated
DNA facilitates the recruitment of MET1, which results
in the methylation of the daughter strand. In addition,
CG maintenance methylation in Arabidopsis also re-
quires Deficient In DNA Methylation 1 (DDM1), a chro-
matin remodeling protein [11,12].
CG methylation is located not only at transposable ele-
ments/intergenic regions, but also in gene bodies. About
one-third of genes have CG methylation in their coding
regions in Arabidopsis (this number is higher in mam-
mals), and gene body CG methylation is also maintained
by MET1 [13]. CG methylation in gene bodies does not
cause silencing, unlike methylation at transposons [14].
In fact, genes harboring body methylation are moder-
ately to highly expressed [14-16]. The purpose of CG
body methylation is still unclear; however, hypotheses on
its potential functions include the suppression of crypticpromoters within coding regions [14,17] and the en-
hancement of accurate splicing [18,19].
Here, we describe the generation of a luciferase (LUC)-
based reporter line that enables screening for genes in-
volved in CG maintenance methylation as well as CHH
methylation via RdDM in Arabidopsis. Due to the exten-
sive CG methylation in the LUC coding region, the re-
porter may also help to understand the functions of gene
body methylation. This line is named Luciferase Harboring
CG Methylation, Low (LUCL) for its high levels of CG
methylation and low levels of LUC expression. Consistent
with the finding that LUCL harbors high levels of CG
methylation, the met1-3 mutation resulted in a release of
DNA methylation at the transgene promoter and through-
out the LUC coding region and drastic de-repression
of LUC expression. Interestingly, introducing ago4-6 and
drm2-6 mutations into LUCL also resulted in the de-
repression in LUC expression, thus LUCL also reports de
novo methylation through RdDM, although RdDM con-
tributes to the silencing of LUCL to a much lesser extent
than CG maintenance methylation. The near complete si-
lencing of LUC expression in LUCL means facile screens
can identify genetic mutations or compounds that release
LUC silencing. The performance of a chemical genetics
screen with LUCL led to several hit compounds. One of
the hit compounds was methotrexate (MTX), which is
known to indirectly prevent the production of S-adenosyl
methionine (SAM), the methyl donor [20]. Treatment of
plants with MTX resulted in reduced DNA methylation
at, and de-repression of, six endogenous RdDM loci that
were examined. Therefore, LUCL could serve as a great
tool to probe the mechanisms of DNA methylation.
Results and discussion
Development of the luciferase reporter line, LUCL
Luciferase-based reporters have been used extensively as
probes for different biological processes [21-24]. Initially,
we aimed to develop a luciferase-based transgene that re-
ports miRNA activity. For this purpose, we generated a
transgene in which the Luciferase (LUC) coding region
fused to a portion of the APETALA2 (AP2) gene that con-
tains the miR172 binding site [21] was behind a dual 35S
promoter from the cauliflower mosaic virus (Figure 1A).
In the same transfer DNA, dual 35S-driven Neomycin
Phosphotransferase II (d35S::NPTII) served as a selecta-
ble marker for plant transformation (Figure 1A). The
transgene was introduced into the RNA-dependent RNA
polymerase6-11 (rdr6-11) mutant background to prevent
post-transcriptional gene silencing [25-27]. We established
two independent Arabidopsis lines containing this trans-
gene, LUCH [21] and LUCL (Luciferase Harboring CG
Methylation, Low), the latter being the topic of this study.
Although the transgene in LUCL and LUCH is identical in
sequence, LUCL has a much lower level of luciferase
Figure 1 LUCL is a multi-copy, single-insertion transgene. (A) LUCL as a multi-copy transgene. Only two tandem copies are shown, with each
copy extending from RB (right border of the transfer DNA) to LB (left border of the transfer DNA). Restriction sites and distances between sites
are noted. The question mark indicates the unknown distance between two tandemly arrayed copies. The stars indicate the miR172 binding sites.
The red lines depict the region used as a probe in the Southern blots in (C) and (D). (B) Luciferase luminescence from LUCL and LUCH seedlings.
Ten-day-old seedlings grown on the same plate were imaged for luciferase luminescence using a CCD camera. The blue spots in the LUCH sector
represent seedlings with luciferase luminescence. The lack of signals in the LUCL sectors represents the absence of luciferase luminescence. (C)
Southern blot analysis of LUCL, Col-0 and LUCH. The gray triangle indicates increasing amounts of genomic DNA from LUCH; the left lane has an
amount of DNA equal to LUCL whereas the right lane contains twice that of LUCL. Genomic DNA was digested with EcoRI and hybridized with a
probe corresponding to the LUC coding region (red line in (A)). The 2.1-kb band corresponding to the LUC-AP2 fragment is indicated by a red
arrow. The intensity of the 2.1-kb band in LUCL is much higher than that in LUCH. (D) Southern blot analysis of LUCL and Col-0. Genomic DNA
was digested with BamHI and hybridized to a probe corresponding to the LUC coding region (red line in (A)). The approximately 6-kb band (red
arrow) represents the possibility of a multi-copy transgene as the distance between the two BamHI sites in two tandemly arrayed copies is 5.4 kb
(not counting the unknown distance between the LB and RB (question mark)).
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tivity in LUCL was practically non-existent and compar-
able to that of the wild type (Col-0) (Figure 1B).
LUCL is a multi-copy, single-insertion transgene
We first characterized the nature of the transgene in-
sertion in LUCL in comparison to LUCH. LUCH was
shown to contain a single-copy transgene at a defined
genomic location [21]. For LUCL, the segregation pat-
tern of kanamycin resistance (conferred by d35S::NPTII)was consistent with the transgene being inserted into a
single genomic locus. However, unlike for LUCH, mul-
tiple attempts to identify the insertion site in LUCL via
thermal asymmetric interlaced PCR (TAIL-PCR) failed.
This suggested that multiple copies of the transgene
may be tandemly or inversely arrayed at the insertion
site. To test this hypothesis, we performed Southern blot
analyses on LUCL and LUCH using the LUC coding re-
gion as a probe. Genomic DNA from LUCL and LUCH
was digested with EcoRI, which should release the LUC-
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responding to the 2.1-kb LUC-AP2 portion was more in-
tense in LUCL than in LUCH when the same amount of
DNA was used (Figure 1C). The intensity of the band
was higher than that of LUCH even when the amount
of LUCH DNA was twice the amount of LUCL DNA
(Figure 1C). Moreover, when LUCL genomic DNA
was digested with BamHI, which has a single site in
the transgene (Figure 1A), a band of approximately
6 kb was observed (Figure 1D, arrow). The size of this
band is consistent with that of a BamHI fragment
from two neighboring, tandemly arrayed transgenes
(Figure 1A and 1D). Thus, LUCL is a multi-copy,
single-insertion transgene.
LUCL does not report miRNA activity
LUCH does not report miRNA activity even though it
contains the miR172 binding site [21]. We wanted to
know whether LUCL, which was derived from the same
transgene in an independent transformation event, is re-
pressed by miR172. If LUCL is repressed by miR172,
then mutations causing reduced miR172 accumulation
are expected to cause the de-repression of LUCL. The
dcl1-7 allele is a partial loss-of-function mutation in
DICER-LIKE1 (DCL1), a key factor in miRNA biogenesis
[28-31]. We crossed dcl1-7 with LUCL and observed lu-
ciferase luminescence in eight different F2 populations
(Additional file 1: Figure S1 and data not shown). No
seedlings in any of the F2 populations (Additional file 1:
Figure S1) showed enhanced luciferase luminescence.
We genotyped some of the seedlings and were able to
identify dcl1-7 homozygous ones. As the F2 seedlings
were selected for kanamycin resistance, all contained the
LUCL transgene, although it was not known whether
they were hemizygous or homozygous for the transgene.
These results suggested that LUCL does not report
miRNA activity.
LUCL is silenced by DNA methylation
Since LUCL is not repressed by miRNA activity, we tes-
ted whether it is repressed by DNA methylation. We
grew LUCH and LUCL seedlings in a medium containing
5-aza-2′-deoxycytidine, a chemical inhibitor of DNA me-
thyltransferase activity [32]. LUCL and LUCH seedlings
treated with 5-aza-2′-deoxycytidine had higher levels
of luciferase luminescence than mock-treated seedlings
(Figure 2A). More importantly, the two lines had nearly
equal levels of luciferase luminescence in the presence of
5-aza-2′-deoxycytidine (Figure 2A), suggesting that the
lack of observable luciferase activity from LUCL was likely
due to DNA methylation. To confirm that the observed
increase in luciferase activity was due to an increase in
transgene expression, we performed reverse transcription-
PCR (RT-PCR) on the seedlings, as shown in Figure 2A.The expression of the LUC transgene as well as the nearby
NPTII transgene was lower in LUCL than in LUCH in
mock-treated seedlings (Figure 2B). The expression of
both transgenes was de-repressed by treatment with
5-aza-2′-deoxycytidine (Figure 2B).
As the experiments above suggested that LUCL was
repressed by DNA methylation, we set out to determine
the levels and sequence contexts of DNA methylation as
well as its distribution along the transgene in LUCL.
We first examined the methylation status of LUCL by
digesting genomic DNA with the restriction endonucle-
ase McrBC followed by PCR amplification of the DNA.
McrBC cuts methylated DNA in the presence of GTP
[33] such that the presence of PCR products indicates
lack of DNA methylation. Upon digestion of LUCL and
LUCH DNA with McrBC, we found that little PCR
products were observed at the 35S region in either line
(Figure 2C). This is consistent with our previous obser-
vation that the d35S is methylated in LUCH [21]. The
lack of PCR products in LUCL suggested that the d35S
in LUCL also harbors DNA methylation. In addition, the
LUC coding region was also methylated in LUCL,
whereas it is not in LUCH (Figure 2C). Therefore, LUCH
and LUCL both harbor 35S promoter methylation and
LUCL also contains coding region methylation. We next
determined the sequence contexts in which LUCL is
methylated. We performed bisulfite sequencing of LUCL
and LUCH at four regions covering the promoter and
the coding region (fragments 1 to 4 in Figure 2D). Specific-
ally, fragment 1 was from the d35S upstream of the LUC
transgene (instead of the d35S upstream of NPTII) and
contained 100 bp of the LUC coding region, and the other
three fragments were from the LUC coding region
(Figure 2D). We found that LUCL harbored higher
levels of CG and CHG methylation and lower levels
of CHH methylation at the d35S region relative to
LUCH (Figure 2E, Region 1). In fact, LUCL exhibited
high levels of CG and CHG methylation throughout the
LUC coding region, whereas in LUCH, DNA methylation
was restricted to the promoter and the 5′ portion of the
coding region (Figure 2E, Regions 2 to 4).
LUCL is repressed by MET1
CG maintenance methylation requires MET1 – loss-of-
function mutations in MET1 result in global hypome-
thylation [2,34]. Since LUCL harbors high levels of CG
methylation, we wanted to see whether the methylation as
well as the TGS status at LUCL requiresMET1. We crossed
LUCL into met1-3 and found that luciferase luminescence
was extremely high in LUCL met1-3 plants (Figure 3A).
This was accompanied by a drastic increase in LUC tran-
script levels as determined by RT-PCR (Figure 3B). We ex-
amined the DNA methylation status in LUCL met1-3 by
bisulfite sequencing analyses at the d35S promoter and the
Figure 2 LUCL is silenced by DNA methylation. (A) Effects of 5-aza-2′-deoxycytidine (5-aza-dC) treatment on LUCH and LUCL. Ten-day-old seedlings
grown on plates with or without 5-aza-2′-dC were imaged for luciferase luminescence using a CCD camera. Col-0 was included as the negative control.
Each blue or white spot represents a seedling. Under the same imaging conditions, 5-aza-dC-treated LUCL and LUCH seedlings had much higher levels of
luciferase luminescence compared to mock (DMSO)-treated seedlings. (B) RT-PCR of mock-treated and 5-aza-2′-dC-treated LUCL and LUCH seedlings in
(A). The LUC and NPTII genes are shown. UBQ5 served as an internal loading control. ‘–RT’ indicates RT-PCR conducted in the absence of reverse
transcriptase during the reverse transcription step. (C) Detection of DNA methylation in LUCH and LUCL by McrBC digestion of genomic DNA followed by
PCR. The+ gels are DNA treated with McrBC. The− gels are DNA treated in the same manner as the + gels except that no McrBC was added. At2g19920
was used as an unmethylated internal control. (D) The d35S::LUC-AP2 transgene in both LUCH and LUCL. The four lines below the rectangles mark the
four regions interrogated by bisulfite sequencing in (E). (E) Detection of DNA methylation at the luciferase reporter gene in LUCH, LUCL, LUCL ago4-6 and
LUCL drm2-6 by bisulfite sequencing. The graphs represent the percentage of DNA methylation (y-axis) at the three different cytosine contexts (x-axis).
The percentage of DNA methylation is also listed in the tables below the graphs. See Additional file 1: Table S2 for bisulfite conversion rates. 5-aza-dC:
5-aza-2′-deoxycytidine; RT-PCR: reverse transcription-PCR. DMSO: Dimethyl sulfoxide; McrBC PCR: digestion of genomic DNA by McrBC followed by PCR.
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Figure 3 met1-3 releases DNA methylation in LUCL. (A) Luciferase luminescence of LUCL and LUCL met1-3. The top panel contains two LUCL
seedlings and the bottom panel contains two LUCL met1-3 seedlings. (B) RT-PCR of LUC transcript levels. UBQ5 was used as an internal control.
(C) Bisulfite sequencing analyses of LUCL (blue bars) and LUCL met1-3 (red bars) reveal that CG methylation is reduced at all four regions tested in
LUCL met1-3. The regions tested are indicated in Figure 2D. RT-PCR: reverse transcription-PCR.
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was dramatically reduced in LUCL met1-3 plants through-
out the four regions (Figure 3C). CHH methylation was
barely affected and CHG methylation was only slightly af-
fected (Figure 3C). Taken together, the high levels of CG
methylation in the promoter and gene body of LUCL are
maintained by MET1, and loss of CG methylation results
in strong LUC expression.
LUCL is also repressed by RdDM
CHH methylation is maintained by RdDM involving the
small RNA effector AGO4 and the de novo methyl-
transferase DRM2. Although the levels of CHH methyla-
tion in LUCL are relatively low (approximately 10% in the
d35S promoter) compared to CG methylation, these levels
are similar to those of CHH methylation at previously
established reporter genes under the control of RdDM.
For example, the Superman 5′ region contained 15%
CHH methylation in the clk-sk line [35]; the RD29A pro-
moter in an RD29A::LUC line had 6% CHH methylation
in the ros1 background in which a DNA demethylase is
mutated [36]. Therefore, it is also possible that LUCL isrepressed by RdDM. To test this, we crossed LUCL with
drm2-6 and ago4-6, mutations in DRM2 and AGO4, re-
spectively. These alleles were previously isolated in our lab
and found to de-repress LUC expression from LUCH [21].
LUCL drm2-6 and LUCL ago4-6 plants had higher levels
of luciferase luminescence than LUCL plants (Figure 4A
and 4B). RT-PCR showed that LUCL drm2-6 and LUCL
ago4-6 plants had higher levels of LUC transcripts
(Figure 4C), but the extent of LUC de-repression in drm2-
6 or ago4-6 was much lower than that in met1-3 (compare
Figure 4C to Figure 3B). We performed bisulfite sequen-
cing in LUCL, LUCL drm2-6 and LUCL ago4-6 to deter-
mine the effects of the drm2 and ago4 mutations on DNA
methylation at the transgene. Little difference in CG or
CHG methylation could be detected at the d35S promoter
or in the LUC coding region in the two mutants compared
to wild type (Figure 2E). For CHH methylation, only the
3′ portion of the LUC coding region showed an approxi-
mately 50% reduction in the two mutants (Figure 2E). We
conclude that LUCL is a sensitive reporter such that even
a small reduction in DNA methylation is reflected by
moderate de-repression of the reporter.
Figure 4 LUCL is weakly de-repressed by mutations in DRM2
and AGO4. (A) Luciferase luminescence of LUCL, LUCH and drm2-6
LUCL seedlings. (B) Luciferase luminescence of LUCL, LUCH and LUCL
ago4-6 seedlings. (C) RT-PCR of LUC transcript levels in LUCL, LUCL
drm2-6 and LUCL ago4-6. UBQ5 was used as an internal control.
RT-PCR: reverse transcription-PCR.
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methylation
Since LUCL is silenced by DNA methylation, we rea-
soned that we could use luciferase luminescence as a
readout to identify chemical compounds that affect
DNA methylation. We screened 24,970 chemical com-
pounds against LUCL seedlings at the two-leaf stage. One
of the hits, methotrexate (MTX), released luciferase activ-
ity in a dose-dependent manner (Figure 5A, B, C, D).
MTX is a compound that inhibits dihydrofolate reductase
(DHFR), an enzyme that participates in tetrahydrofolate
(THF) synthesis. DHFR catalyzes the conversion of
dihydrofolate (DHF) to THF [37] (Figure 5M). The energy
given off by the conversion of THF to 5-methyl THF cata-
lyzes the production of methionine from homocysteine
and vitamin B12. Therefore, MTX ultimately prevents the
production of the methyl donor, S-adenosyl methionine
(SAM) [20] (Figure 5M). MTX is found in two forms, D
and L (in reference to the molecule’s chirality) (Figure 5K,
arrows). While we tried to perform the secondary valida-
tions with the compound, we found that the compound
pulled from the initial screen possessed D chirality
(Figure 5K, bottom), and the vendor discontinued the
product. Thus, we tested LUCL with L-MTX and a ra-
cemic mixture of D- and L-MTX. Both L-MTX and the
racemic mixture were able to release luciferase activity of
LUCL at concentrations lower than that of D-MTX
(Figure 5E, F, G, H, I, J). L-MTX is more efficiently taken
up by human cells than D-MTX [38]; perhaps this is also
true in plants. We tested whether MTX released DNA
methylation at LUCL by McrBC-PCR. Indeed, we found
that D-MTX released DNA methylation at the d35S pro-
moter in a concentration-dependent manner (Figure 5L).
Next, we examined whether MTX affects DNA methyla-
tion and/or transcriptional silencing of endogenous loci.
Seedlings were treated with DMSO (control) or a racemic
mixture of MTX, and the expression of the luciferase trans-
gene as well as six endogenous loci known to undergo
RdDM was determined by RT-PCR. MTX led to the de-
repression of the luciferase transgene and the six endogen-
ous loci (Figure 5N). The DNA methylation status of the six
loci, as well as Chr2_1882324 (another locus that harbors
DNA methylation) and the luciferase transgene, was evalu-
ated by McrBC-PCR. In addition to the d35S promoter, the
luciferase coding region showed reduced DNA methylation
in MTX-treated seedlings (Figure 5O). MTX treatment also
led to reduced DNA methylation at the six endogenous loci
(Figure 5O). The effect of MTX was similar to that of the
nrpe1 mutation (in the largest subunit of Pol V) in the re-
duction of DNA methylation at these loci (Figure 5O).
Conclusions
We developed a luciferase-based reporter transgene (LUCL)
that reports TGS by MET1-mediated CG methylation as
Figure 5 MTX releases DNA methylation of LUCL. (A-J) Luciferase luminescence of LUCL seedlings treated with various compounds. (A)
DMSO-treated LUCL seedlings. (B-D) D-MTX-treated LUCL seedlings. (E-G) LUCL treated with a mixture of D- and L-MTX. (H-J) L-MTX-treated LUCL
seedlings. The concentrations of the chemicals are as indicated in (B-J). (K) Chemical structures of L-MTX (top) and D-MTX (bottom). The arrows
indicate the position of chirality of the two forms. (L) McrBC-PCR-based methylation assay of LUCL seedlings treated with D-MTX. DC: DMSO-
treated Col-0 control, D: DMSO-treated LUCL. The gray triangle represents increasing concentrations of MTX (2 μM for the left lane and 8 μM for
the right lane). (M) MTX inhibits SAM biosynthesis to indirectly affect gene silencing via DNA methylation. MTX inhibits the conversion of DHF to
THF. Under normal circumstances, the energy given off by the conversion of THF to 5-methyl THF promotes the production of methionine from
homocysteine and vitamin B12. (N) Expression of LUCL and six endogenous RdDM loci in DMSO (control)- and MTX-treated seedlings as
determined by RT-PCR. (O) McrBC-PCR-based methylation assay of LUCL seedlings treated with DMSO (D) or MTX (M), and non-treated nrpe1-11
seedlings (n). Two biological replicates gave similar results and only one is shown here. +: McrBC digested; -: non-digested. The six loci in the
bottom panel are known to undergo RdDM. LUCp1 to LUCp4 correspond to regions 1 to 4 of the LUCL transgene in Figure 2D. Chr2_1882324 is a
region that harbors DNA methylation in wild type. At2g19920 is a gene that does not harbor any DNA methylation and is used as an internal
loading control. DHF: dihydrofolate; DMSO: dimethyl sulfoxide; McrBC-PCR: digestion of genomic DNA by McrBC followed by PCR; MTX:
methotrexate; RT-PCR: reverse transcription-PCR; SAH: S-adenosylhomocysteine; SAM: S-adenosyl methionine; THF: tetrahydrofolate.
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reporter systems [2,39], LUCL is suitable for identifying
positive players involved in de novo methylation by RdDM
and CG maintenance methylation. The lack of luciferase
luminescence from LUCL allows for facile genetic or
chemical screens in which mutations or compounds that
release DNA methylation could be easily identified based
on the appearance of luciferase luminescence. Using this
reporter line, we have screened approximately 25,000 small
molecules and obtained two reproducible hits. One of
these hits, MTX, serves as a proof-of-concept as its nega-
tive function in methyl biogenesis is known [20]. Another
feature of this reporter system is that it harbors high levels
of DNA methylation in the LUC coding region. Thus,
LUCL may be used as a probe to dissect the molecular
mechanism and function of gene body methylation.
Methods
Plant material
Arabidopsis mutants used in this study, rdr6-11 [25],
dcl1-7 [29], met1-3 [40], drm2-6 [21], ago4-6 [21] and
nrpe1-11 [41,42], are in the Col-0 background.
Growth conditions and luciferase live imaging
Arabidopsis thaliana seeds were surface-sterilized with
30% bleach, planted on Murashige and Skoog (MS)
agar plates containing kanamycin (30 mg/mL for lines
containing LUCL) and stratified at 4°C for 2 days. Seedlings
were grown at 23°C under continuous light for 10 days. All
experiments with LUCL and LUCH were performed with
10-day-old seedlings. For the chemical screen, two seeds
were plated into each well in a 96-well plate. After 7 days,
chemicals were added in each well, except for the first col-
umn, in which DMSO was added as a negative control.
Three days later, the plates were imaged for luciferase ac-
tivity [21]. For the secondary screening of MTX, D- and/or
L-MTX (Sigma) were added individually per well. After
images were taken, plants were collected for subsequent
methylation assays. For luciferase live imaging, 1 mM lucif-
erin (Promega) in 0.01% Triton X-100 was sprayed onto
the seedlings, which were incubated in the dark for 5 min
before images were taken. Luciferase images were taken
using a Stanford Photonics Onyx Luminescence Dark Box
with a Roper Pixis 1024B camera at the UC Riverside Gen-
omics Core Facility.
Construction of transgene and Southern blot analysis
LUCL and LUCH are two independent transgenic lines
containing the same transgene, which has been previously
described [21]. Southern blot analysis was performed
according to the standard protocol [43] to evaluate the copy
number of LUCL using the full-length LUC coding region
as the probe. The probe was amplified with primers lucp6
and lucp7, and radiolabeled with the RPN1633 RediprimeII random prime labeling system (GE Healthcare). Primers
used were previously described and are listed in [21] and
Additional file 1: Table S1.
Analysis of DNA cytosine methylation
For the McrBC-PCR assay, two reactions were set up for
each genomic DNA sample: McrBC treated and untreated.
Next 400 ng genomic DNA was digested with McrBC
(New England Biolabs) for 30 min at 37°C in a 20 μl re-
action. Then 1 μl of restricted genomic DNA was used
as the template and genomic regions corresponding to
the LUCL transgene or endogenous loci were amplified.
At2g19920 was used as a loading control. See Additional
file 1: Table S1 for sequences of primers.
For bisulfite sequencing, in Figure 2, 1 μg of RNase-
treated genomic DNA was subjected to bisulfite conver-
sion using the EpiTect Bisulfite Kit per the manufacturer’s
instructions (Qiagen). For Figure 3, 400 ng of RNase-
treated genomic DNA derived from leaf tissue from LUCL
and LUCL met1-3 plants was subjected to bisulfite conver-
sion using the MethylCode™ Bisulfite Conversion Kit per
the manufacturer’s instructions (Invitrogen). The PCR re-
actions with primers YZ 35S Bis F and YZ LUC Bis R as
well as another three sets of primers that covered the LUC
coding region were performed using the converted DNA
as a template as described previously [21], purified via gel
extraction per the manufacturer’s instructions (Qiagen or
Zymo), and cloned into the pGEM-T Easy vector
(Promega). A minimum of 24 clones were sequenced for
each sample and unique clones were analyzed for DNA
methylation with Kismeth [44,45]. To determine the con-
version efficiency, PCR reactions were conducted with
primers specific for chloroplast DNA using the same
converted DNA as above and the PCR products were
processed in the same manner. At least 15 unique clones
were selected for analysis by Kismeth. As chloroplast DNA
is unmethylated, conversion efficiency could be deter-
mined. See Additional file 1: Table S2 for conversion rates
of various samples. For 5-aza-2′-deoxycytidine (Sigma)
treatment, seeds were germinated and grown on an MS
agar medium containing 1% sucrose and 7 μg/mL of the
chemical for 2 weeks and luciferase images were taken.
RT-PCR
RNA was isolated with Tri-reagent (Molecular Research
Center) from 10-day-old seedlings from LUCL met1-3,
LUCL ago4-6 and LUCL drm2-6 plants as previously de-
scribed [46]. For the RT-PCR in Figures 3 and 4, older
leaf tissue from LUCL met1-3, LUCL ago4-6, and LUCL
drm2-6 plants was utilized. For the RT-PCR in Figure 5,
10-day-old, chemical-treated seedlings were used. cDNA
was synthesized from 5 μg (14 μg for Figure 5) of DNaseI
(Invitrogen)-treated total RNA using reverse transcript-
ase (Fermentas) and oligo-dT (Fermentas) as previously
Dinh et al. Silence 2013, 4:1 Page 10 of 11
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Additional file 1: Table S1.
Chemical screening
Small molecule compounds used for the chemical screen
consist of: 1,200 from LifeSciences, 2,000 from Spectrum
and 400 from Myria/Sigma from the UCR small com-
pounds collection [47]; 4,204 from a triazine-tagged li-
brary [48,49]; 2,768 from Clickables [50] and 3,580 from
LATCA [51]. The screening was performed at the
Chemical Screening Facilities at UC Riverside.
Additional file
Additional file 1: Figure S1. LUCL is not regulated by the miRNA
pathway. Luciferase luminescence of LUCL, LUCH, and seedlings from
several F2 populations (#101, 103 and 104) of dcl1-7 crossed to LUCL. In
the F2 population, none of the seedlings showed de-repression of
luciferase activity. Table S1. DNA oligonucleotides used in this study.
Table S2. Conversion rates for the bisulfite sequencing experiments.
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